Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-023958
Filing Date
2024-09-25
Accepted
2024-09-25 16:45:50
Documents
2
Period of Report
2024-09-25

Document Format Files

Seq Description Document Type Size
1 form3-09252024_080947.html 3  
1 form3-09252024_080947.xml 3 5303
2 ex24-09252024_080951.htm EX-24 6929
  Complete submission text file 0001415889-24-023958.txt   13539
Mailing Address
Business Address
GOLDSTEIN DOV A MD (Reporting) CIK: 0001120478 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-42279 | Film No.: 241325214

Mailing Address 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address 1445A SOUTH 50TH STREET RICHMOND CA 94804 510-806-1445
BioAge Labs, Inc. (Issuer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)